Should Value Investors Buy Tenet Healthcare (THC) Stock?

27.08.25 15:40 Uhr

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.Tenet Healthcare (THC) is a stock many investors are watching right now. THC is currently sporting a Zacks Rank #1 (Strong Buy), as well as an A grade for Value. The stock is trading with a P/E ratio of 11.4, which compares to its industry's average of 13.24. Over the last 12 months, THC's Forward P/E has been as high as 15.40 and as low as 8.81, with a median of 12.18. We also note that THC holds a PEG ratio of 0.77. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. THC's industry has an average PEG of 1.25 right now. THC's PEG has been as high as 1.30 and as low as 0.55, with a median of 0.82, all within the past year.Finally, our model also underscores that THC has a P/CF ratio of 7.12. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 7.39. THC's P/CF has been as high as 7.19 and as low as 2.83, with a median of 4.15, all within the past year.These are only a few of the key metrics included in Tenet Healthcare's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, THC looks like an impressive value stock at the moment.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Tenet Healthcare Corp.

Wer­bung

Analysen zu Tenet Healthcare Corp.

DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
03.11.2011Tenet Healthcare overweightBarclays Capital
04.08.2011Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
03.11.2011Tenet Healthcare sector performRBC Capital Markets
21.07.2010Tenet Healthcare neutralUBS AG
02.06.2010Tenet Healthcare DowngradeRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
28.01.2009Tenet Healthcare underperformRBC Capital Markets
01.10.2008Tenet Healthcare DowngradeUBS AG
08.11.2007Tenet Healthcare underweightLehman Brothers Inc.
08.11.2007Tenet Healthcare underperformCowen and Company, LLC
11.09.2007Tenet Healthcare underweightLehman Brothers Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen